Silent thyroiditis medical therapy

Revision as of 13:28, 21 September 2017 by Furqan M Muhammad (talk | contribs)
Jump to navigation Jump to search

Silent thyroiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Silent thyroiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Silent thyroiditis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Silent thyroiditis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Silent thyroiditis medical therapy

CDC on Silent thyroiditis medical therapy

Silent thyroiditis medical therapy in the news

Blogs on Silent thyroiditis medical therapy

Directions to Hospitals Treating Silent thyroiditis

Risk calculators and risk factors for Silent thyroiditis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]

Overview

Pharmacologic medical therapies for silent thyroiditis include beta blockers for thyrotoxicosis symptoms and Levothyroxine is required if the patient develops hypothyroidism following the resolution of the hyperthyroid state.[1][2][3]

Medical Therapy

Silent thyroiditis

The drugs used in the treatment of silent are:

  • For thyrotoxic symptoms
    • Preferred regimen (1):atenolol: 25-200mg per day orally
    • Preferred regimen (2):metoprolol: 25-200mg per day orally
  • For hypothyroidism
  • Preferred regimen (1):Synthetic levothyroxine (L-T4): 1.6–1.8 μg/kg per day orally


References

  1. Samuels MH (2012). "Subacute, silent, and postpartum thyroiditis". Med. Clin. North Am. 96 (2): 223–33. doi:10.1016/j.mcna.2012.01.003. PMID 22443972.
  2. Schubert MF, Kountz DS (1995). "Thyroiditis. A disease with many faces". Postgrad Med. 98 (2): 101–3, 107–8, 112. PMID 7630839.
  3. Singer PA (1991). "Thyroiditis. Acute, subacute, and chronic". Med. Clin. North Am. 75 (1): 61–77. PMID 1987447.


Template:WikiDoc Sources